A diagnostic test to examine early improvement as a predictor of later response to lurasidone in bipolar depression.

Patients who did not show an early response at Week 2 cannot be predicted with a high probability to also show poor improvement at Week 6. In fact, some patients who did not show early response at 2 weeks might have marked improvement at 6 weeks.